Concepedia

Elsa Sousa

ES

8

Publications

462

Citations

8

H-Index

2013

Active since

Affiliations

Instituto Português de Oncologia Francisco Gentil(Current)

Universidade do Porto

Polytechnic Institute of Porto

University of Cambridge

Wellcome/MRC Cambridge Stem Cell Institute

Elsa Sousa is an author at Instituto Português de Oncologia Francisco Gentil specializing in medicine, pharmacology, and cell biology.

ORCID

Top concepts

Publications per year

2013–2019

8

Publications

8

SMYD3 contributes to a more aggressive phenotype of prostate cancer and targets Cyclin D2 through H4K20me3

Filipa Quintela Vieira, Pedro Costa‐Pinheiro, Diogo Almeida-Rios et al. · Oncotarget · 2015 · 75 citations · Full text

Enoxacin inhibits growth of prostate cancer cells and effectively restores microRNA processing

Elsa Sousa, Inês Graça, Tiago Baptista et al. · Epigenetics · 2013 · 64 citations · Full text

, , +13

Anti-neoplastic properties of hydralazine in prostate cancer

Inês Graça, Elsa Sousa, Pedro Costa‐Pinheiro et al. · Oncotarget · 2014 · 62 citations · Full text

, , +10

Anti-Tumoral Effect of the Non-Nucleoside DNMT Inhibitor RG108 in Human Prostate Cancer Cells

Inês Graça, Elsa Sousa, Tiago Baptista et al. · Current Pharmaceutical Design · 2014 · 59 citations · Full text

MicroRNA-27a-5p regulation by promoter methylation and MYC signaling in prostate carcinogenesis

Daniela Barros‐Silva, Pedro Costa‐Pinheiro, Henrique O. Duarte et al. · Cell Death and Disease · 2018 · 57 citations · Full text

Rows per page

1–5 of 8